company background image
2737 logo

Sunflower Pharmaceutical GroupLtd SZSE:002737 Stock Report

Last Price

CN¥29.24

Market Cap

CN¥17.4b

7D

-2.9%

1Y

19.9%

Updated

13 Jun, 2024

Data

Company Financials

Sunflower Pharmaceutical Group Co.,Ltd

SZSE:002737 Stock Report

Market Cap: CN¥17.4b

2737 Stock Overview

Engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally.

2737 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends2/6

Sunflower Pharmaceutical Group Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sunflower Pharmaceutical GroupLtd
Historical stock prices
Current Share PriceCN¥29.24
52 Week HighCN¥30.79
52 Week LowCN¥20.54
Beta0.33
1 Month Change-3.66%
3 Month Change8.70%
1 Year Change19.93%
3 Year Change94.03%
5 Year Change90.99%
Change since IPO122.36%

Recent News & Updates

Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 07
Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

Recent updates

Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 07
Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

Apr 16
Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

Mar 04
We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

Shareholder Returns

2737CN PharmaceuticalsCN Market
7D-2.9%-0.8%-0.9%
1Y19.9%-9.9%-14.4%

Return vs Industry: 002737 exceeded the CN Pharmaceuticals industry which returned -9.9% over the past year.

Return vs Market: 002737 exceeded the CN Market which returned -14.4% over the past year.

Price Volatility

Is 2737's price volatile compared to industry and market?
2737 volatility
2737 Average Weekly Movement4.5%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.1%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 002737 has not had significant price volatility in the past 3 months.

Volatility Over Time: 002737's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20055,776Yi Guanwww.kuihuayaoye.com

Sunflower Pharmaceutical Group Co.,Ltd engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally. The company produces chemical and biological medicines, and health care products. It also provides products covering various therapeutic areas, including pediatrics, gynecology, digestive system, respiratory and cold, rheumatic bone disease, and cardiovascular and cerebrovascular; supplements; and antibiotics and children’s medicinal products.

Sunflower Pharmaceutical Group Co.,Ltd Fundamentals Summary

How do Sunflower Pharmaceutical GroupLtd's earnings and revenue compare to its market cap?
2737 fundamental statistics
Market capCN¥17.41b
Earnings (TTM)CN¥968.19m
Revenue (TTM)CN¥5.45b

17.6x

P/E Ratio

3.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2737 income statement (TTM)
RevenueCN¥5.45b
Cost of RevenueCN¥2.43b
Gross ProfitCN¥3.02b
Other ExpensesCN¥2.05b
EarningsCN¥968.19m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.66
Gross Margin55.35%
Net Profit Margin17.76%
Debt/Equity Ratio0.3%

How did 2737 perform over the long term?

See historical performance and comparison

Dividends

5.1%

Current Dividend Yield

90%

Payout Ratio

Does 2737 pay a reliable dividends?

See 2737 dividend history and benchmarks
When do you need to buy 2737 by to receive an upcoming dividend?
Sunflower Pharmaceutical GroupLtd dividend dates
Ex Dividend DateJun 14 2024
Dividend Pay DateJun 14 2024
Days until Ex dividend1 day
Days until Dividend pay date1 day

Does 2737 pay a reliable dividends?

See 2737 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.